Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

32.54 +2.62 (+8.76%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Is Elon Musk Stepping Down as Head of Twitter? ↗
Elon Musk is in the news Monday after the billionaire held a poll asking if he should step down as head of social media company Twitter. 
Via InvestorPlace
News headline image
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Is Cosmos Health (COSM) Stock Down 58% Today? ↗
Cosmos Health (COSM) stock is falling hard on Monday after the healthcare company's shares underwent a major rally on Friday! 
Via InvestorPlace
News headline image
Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning ↗
Good news can come in different forms. 
Via The Motley Fool
News headline image
Recap: Viking Therapeutics Q3 Earnings ↗
Viking Therapeutics (NASDAQ:VKTX) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Recap: Viking Therapeutics Q2 Earnings ↗
Viking Therapeutics (NASDAQ:VKTX) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
FDA Lifts Clinical Hold On Viking Therapeutics' Rare Metabolic Disorder Study ↗
 
Via Benzinga
News headline image
Why Is Viking Therapeutics (VKTX) Stock Up 67% Today? ↗
Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company. 
Via InvestorPlace
News headline image
US Stocks Slightly Lower; Nasdaq Down 100 Points ↗
U.S. stocks traded slightly lower this morning, with the Nasdaq Composite dropping around 100 points on Monday. 
Via Benzinga
News headline image
Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today ↗
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Monday, in sympathy with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced a suc 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
My 3 Top Biotech Stock Picks for 2023 ↗
Biotech stocks are set to shine in 2023. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For October 26, 2022 ↗
Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly loss at $0.41 per share on revenue of $4.90 billion. 
Via Benzinga
News headline image
Earnings Outlook For Viking Therapeutics ↗
Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Viking... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Viking Therapeutics Earnings Preview ↗
Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that Viking... 
Via Benzinga
News headline image
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary ↗
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness... 
Via Benzinga
News headline image
Earnings Scheduled For July 27, 2022 ↗
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter. 
Via Benzinga
News headline image
U.S. FDA Lifts Clinical Hold On Viking Therapeutics' Initial-Stage Genetic Disorder Study ↗
Viking Therapeutics (NASDAQ: VKTX) announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold placed on the clinical trial of VK0214 in patients with X-linked... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
Insiders Buy More Than $50M Of 3 Penny Stocks ↗
Gold futures traded lower on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Unicycive Therapeutics (NASDAQ:UNCY) shares moved upwards by 9.9% to $1.0 during Wednesday's after-market session. The company's market cap stands at $15.0 million. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
During Monday's trading, 1214 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
During the Thursday's session, 100 stocks hit new 52-week lows. 
Via Benzinga
News headline image
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
On Tuesday, 540 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.